九聯科技(688609.SH):目前公司的邊緣計算類產品有九聯邊緣計算小站、鴻蒙 AI 算力開發板(UnionpiTiger)等
格隆匯1月9日丨九聯科技(688609.SH)接受特定對象調研時表示, 目前公司的邊緣計算類產品有九聯邊緣計算小站、鴻蒙 AI 算力開發板(UnionpiTiger)等,公司的信創產品主要涉及信創的辦公主機、會議主機、政務一體機以及信創雲計算等領域。公司於 2021 年底開始研發信創的智算產品,採用的核心方案為華為海思的 PANGUM900。PANGU M900 是華為研發的針對信創市場的高性能高集成度計算平台。集成高性能華為自研 NPU,我公司研發的信創智算產品可作為華為盤古大模型邊緣端側的算力底座。我們提供邊緣端和終端的相關算力產品,比如邊緣計算機產品和智能 IPC 產品等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.